Z
Zevra Therapeutics, Inc.
ZVRA · NASDAQ · Healthcare · 669M
Closing price
$11.39
+3.55% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
7.6×
Price / net assetsP/B
4.1×
Enterprise value / EBITDAEV/EBITDA
6.4×
Free cash flow yieldFCF yield
-0.4%
Return on equityROE
53.8%
Operating margin
-4.0%
Net debt / EBITDAbalance-sheet strength
0.0×
Interest coverage
-0.5×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.